Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-054518

10% owner sold 24,309 shares at an average $29.50 ($717,218)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
UBS Oncology Impact Fund L.P. 10% owner 2021-08-31 Sale −1,285 $29.43 $37,818 7,759,840 D: show line 1 in the form
UBS Oncology Impact Fund L.P. 10% owner 2021-08-31 Sale −1,553 $30.14 $46,807 7,758,287 D: show line 2 in the form
UBS Oncology Impact Fund L.P. 10% owner 2021-09-01 Sale −5,714 $29.47 $168,392 7,752,573 D: show line 3 in the form
UBS Oncology Impact Fund L.P. 10% owner 2021-09-02 Sale −15,757 $29.46 $464,201 7,736,816 D: show line 4 in the form
Open-market sales · 24,309 sh · avg $29.50 · $717,218
Loading xslF345X03/doc4.xml…